TCTR20200515002已完成未知
Golimumab in refractory non-infectious ocular inflammatory disease in Siriraj hospital
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 10 Years 至 40 Years（—）
- 性别
- All
入选标准
- •1) non-infectious eye inflammation which could not be controlled with prednisolone ≥ 10 mg/day combined with 2 immunosuppressive agents (refractory to treatment) or having adverse effects which required IMS cessation
- •2) patients agree to use GLM treatment (50 mg subcutaneous injection every 4 weeks) and are able to follow the treatment schedule
排除标准
- •1) patients affected with or suspected of infectious ocular inflammation
- •2) patients with active or history of tuberculosis
- •3) known allergy history of golimumab or related products
- •4) pregnant subjects
研究者
相似试验
进行中（未招募）
4 期
Steroids and/ or Non-steroidal Anti-inflammatory Drugs in the Postoperative Regime After Trabeculectomy.GlaucomaNCT04054830Rigshospitalet, Denmark70
已完成
不适用
Intravitreal ranibizumab for patients with neovascular age-related macular degeneration with good baseline visual acuityneovascular age-related macular degenerationJPRN-UMIN000015073Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences40
招募中
不适用
Treating Glaucoma with High Intensity Focused UltrasoundCTRI/2017/01/007748EYE TECH CARE24
进行中（未招募）
不适用
Adjuvant treatment of Graves´ ophthalmopathy with NSAID (aGO study) - aGO studyGraves´ophthalmopathyEUCTR2005-000832-26-SEDepartment of Endocrinology300
尚未招募
3 期
Prophylactic Ranibizumab in the fellow eye in patients with wet type Age Related Macular DegeneratioWet Age Related Macular Degeneration (AMD)Eye - Diseases / disorders of the eyeACTRN12614000511639El Gawhara eye center ,Egypt134